phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

PhRMA_Value_Collaborative_Reversed

With the rapid movement towards value-based payment and delivery in health care, it is critical not to leave one of the key players behind: the patient.  

Structured well, shared decision making (SDM) tools offer an important, patient-centered solution for improving care quality and value. A new report released last week -- National Quality Partners Playbook: Shared Decision Making in Healthcare -- points the way forward. PhRMA is proud to support the development of the playbook, a culmination of the National Quality Forum’s work to convene leading stakeholders and patient advocates to advance best practices for shared decision making. 

There is growing evidence that informed and empowered patients who are engaged in collaborative dialogue and decisions with their clinicians have the potential to drive better health outcomes, improve care quality and make our health care system more efficient. A recent report released by Avalere showed that:  

  • Early evidence suggests that SDM can improve key measures in health care quality that matter to patients and could drive more appropriate health care utilization
  • SDM has the potential to play a critical role in the success of value-based payment models, but current evidence is only reflective of emerging stages of SDM practice and science
  • More comprehensive, patient-centered approaches to assessing value can elevate SDM to the next level in supporting the move towards value-based health care system

The timely release of the playbook takes the crucial step of providing actionable, practical guidance for clinicians and health care organizations seeking to implement or strengthen shared decision making within their care settings. The playbook suggests:

  • Engaging patients and health care providers in the development of SDM processes and tools
  • Identifying relevant outcomes via a collaborative (co-designed) process that includes patients, clinicians, administrators and other stakeholders to ensure validity
  • Selecting and implementing high-quality decision aids that meet the National Standards for the Certification of Patient Decision Aids to help patients make informed decisions
  • Establishing accountability and incentives for engagement in SDM

The playbook is an important resource to spur meaningful change in the way care is provided, and overcome challenges to making SDM a common practice in health care. We hope that all stakeholders can leverage NQF’s detailed recommendations so our health care system can to implement strong shared decision-making processes and tools to support high value care.

Randy Burkholder

Randy Burkholder is a Vice President of Policy and Research at PhRMA. He has over 17 years experience in health care policy, advocacy and communications in the medical technology and pharmaceutical industries.

Incomplete evaluations undermine patient access to transformational medicine

October 5, 2023

You won’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities

June 16, 2022

PhRMA presents research at ISPOR 2022

May 26, 2022

Innovative contracts continue to gain traction and improve quality of care

May 2, 2022

Study finds nearly half of payers believe innovative contracts can lead to lower patient out-of-pocket costs

May 17, 2021

Growth in innovative, value-based contracts holds promise for the health system and for patients

September 24, 2020

Innovative contracts drive access for patients and value for the system

September 9, 2020

ICYMI: Patients saved nearly $800,000 out of pocket through innovative contracting arrangements

April 20, 2020

Low-value health care costs $345B each year and provides little benefit

February 26, 2020

Addressing barriers that inhibit value-based contracts

February 21, 2020

Guest post: Value-based agreements can improve outcomes and even save patients money at the pharmacy counter

November 7, 2019

New data show how ICER’s value framework could prevent or delay access to treatments for Medicaid patients across the country

November 4, 2019

5 Ways to improve ICER’s value assessment framework

June 20, 2019

Assessing value top of mind at ISPOR 2019

June 5, 2019

New analysis shows 820,000 prescriptions would be in jeopardy if ICER’s value framework is used in Medicaid

March 20, 2019

Value assessments should include all the outcomes that matter to patients and families

February 20, 2019

Event tomorrow: Leaders convene to discuss solutions to advance value-driven health care

October 2, 2018

New whitepaper identifies reasons why ICER’s cost-effectiveness analyses are not useful for payers

September 19, 2018

Guest post: Developing new payment models to ensure patients have access to high-investment therapies

September 6, 2018

Number of value-based contracts continues to rise

August 27, 2018

ICER’s budget impact threshold: Sounding a false alarm on affordability and access

July 24, 2018

PhRMA submission to HHS on blueprint to lower drug prices and reduce out-of-pocket costs

July 16, 2018

How ICER’s assessment of a new class of migraine treatments fails patients

July 10, 2018

Aspen Spotlight Health: Discussing the forefront of innovation

June 21, 2018

New analysis shows that HTA organizations may frequently restrict access to cancer treatments

June 1, 2018

New analysis shows negative impact of ICER’s value framework on patient access in Medicare Part B

May 31, 2018

ICYMI: Recent survey adds to growing body of research on barriers to innovative payment approaches

May 29, 2018

Event tomorrow: Improving patient access to lifesaving medicines

May 22, 2018

Reality check: Value-based contracts are good for patients

April 25, 2018

Video: Barriers to results-based contracts

April 17, 2018

ICYMI: Research shows promise of innovative payment arrangements in reducing costs, improving access

March 15, 2018

Clarity around anti-kickback statute needed to promote innovative payment arrangements

January 10, 2018

Video: What is a results-based contract?

November 13, 2017

PhRMA Foundation recognizes inaugural Challenge Award recipients

October 6, 2017

Johnson & Johnson, Pfizer, Walgreens and other CEOs discuss value in the future of health care

September 21, 2017

The journey to better health care requires a holistic view

September 18, 2017

Medicare Monday: How Part B has evolved over the years

July 24, 2017

Modernizing FDA regulations to advance a value-driven health care system

June 8, 2017

PhRMA CEO in Forbes - How to negotiate better deals for prescription medicines

June 2, 2017

ICYMI: Avalere and FasterCures develop new value framework from patient perspective

May 31, 2017

ICYMI: Innovative payment models helping provide patient access to new medicines

May 5, 2017

RA medicines often demonstrate far greater benefits to patients than initially understood

April 5, 2017

New analysis: More than half of patients’ out-of-pocket spending for brand medicines is based on full list price

March 29, 2017

Stakeholders Agree: Modernize the legal framework to support move to value-driven health care

March 6, 2017

How do multiple sclerosis patients define value?

February 24, 2017

PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check

February 9, 2017

VIDEO: PhRMA CEO discusses #GOBOLDLY campaign and White House meeting with CNNMoney’s Maggie Lake

February 3, 2017

The Value Collaborative: Advancing private market solutions to achieve better health, lower costs

January 31, 2017

Improving care quality by engaging patients in shared decision making

Quality Metrics

Value-Driven Health Care

The Value Collaborative

Improving care quality by engaging patients in shared decision making

March 22, 2018

Improving care quality by engaging patients in shared decision making

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list